NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R01 Clinical Trial Optional)
ID: 343429Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the R01 grant under the funding opportunity titled "NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity." This initiative aims to support independent research projects that align with the 2022-2026 National Institute of Nursing Research (NINR) Strategic Plan, focusing on a holistic approach to health and addressing significant health challenges while promoting health equity. The program encourages diverse perspectives in research and is open to a wide range of eligible applicants, including various educational institutions and organizations, with no budget restrictions as long as they reflect project needs. Interested applicants should note that the application submission period runs from October 10, 2022, to October 5, 2024, with a maximum project duration of five years. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The National Institutes of Health (NIH) is soliciting R01 grant applications focused on independent research projects aligned with the NINR 2022-2026 Strategic Plan. The funding opportunity aims to promote research that adopts a holistic approach to health, seeking solutions to pressing health challenges while advancing health equity. Key dates for application submissions span from October 10, 2022, to October 5, 2024, with a maximum project period of five years and no budget restrictions, provided they reflect project needs. Eligible applicants include various higher education institutions, nonprofits, for-profits, and governments, with strong encouragement for applications from underrepresented groups. A vital component is the Plan for Enhancing Diverse Perspectives (PEDP), integrated into applications to expand inclusivity in research. The applications will be evaluated based on criteria including significance, investigator qualifications, innovative approaches, methodology, and research environment. Non-responsive applications will include those purely exploring basic biological mechanisms or drug developments without addressing contexts tied to the NINR research lenses. This holistic initiative underscores the commitment to improving health outcomes through intersectoral collaboration in nursing research.
    Similar Opportunities
    NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R21 Clinical Trial Optional grant for exploratory and developmental research projects aimed at optimizing health and advancing health equity. This initiative encourages applicants to propose innovative research that aligns with the NINR Strategic Plan (2022-2026) and employs nursing's holistic approach to address critical health challenges while fostering diversity and inclusion through a required Plan for Enhancing Diverse Perspectives (PEDP). Eligible organizations include higher education institutions, nonprofits, and local governments, with a budget limit of $275,000 over two years. Interested applicants should note that the application deadline is May 7, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-22-231.html for further details.
    Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Healthcare for Older Adults from Populations that Experience Health Disparities" under the R01 Clinical Trial Optional grant program. This initiative aims to enhance the science and implementation of healthcare research focused on older adults from populations facing health disparities, specifically targeting improvements in screening, diagnostic, and clinical care guidelines, as well as fostering shared decision-making between clinicians and patients. The research is particularly significant for addressing the unique health challenges encountered by older adults from racial and ethnic minorities and underserved communities, emphasizing innovative care solutions that consider social determinants of health. Interested applicants can find more information and apply through the NIH Grants website, with the application opening on January 5, 2025, and a close date set for January 7, 2028. For inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) to support innovative research aimed at addressing minority health and health disparities in the United States. This grant invites applications for short-term exploratory projects that can either pioneer new advancements or build upon previous findings, with a maximum funding amount of $275,000 available for a two-year project period, limiting annual requests to $200,000. The program emphasizes the importance of diverse representation among applicants and encourages partnerships with relevant stakeholders, focusing on NIH-designated health disparity populations through various research methodologies. Interested applicants can find more information and submission guidelines at the provided link, with the application deadline set for May 7, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Research Project Grant (Parent R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Research Project Grant (Parent R01 Clinical Trial Required) to support specified clinical research projects that align with the missions of various NIH institutes. Applicants are required to propose at least one clinical trial, focusing on significant health-related research areas, and must comply with the NIH Grants Policy Statement. This funding opportunity is crucial for advancing medical science and improving patient care, emphasizing innovation and scientific merit in addressing important health issues. The application deadline is January 7, 2025, and interested parties can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further inquiries. More details can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PA-20-183.html.
    Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)" aimed at supporting research that addresses barriers to the adoption and sustainability of evidence-based health interventions. The initiative encourages studies that promote equitable dissemination among underrepresented communities and explore the de-implementation of ineffective practices, emphasizing the importance of interdisciplinary collaboration and stakeholder engagement. Eligible applicants include a wide range of entities such as educational institutions, nonprofits, and government organizations, with funding amounts determined by NIH appropriations and the quality of applications. The application deadline is May 7, 2025, and interested parties can find more information and contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.
    Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)," aimed at supporting studies that address barriers to the adoption and sustainability of evidence-based health interventions, particularly in underserved communities. The initiative encourages research that promotes equitable access to effective practices and explores methods for discontinuing ineffective or harmful interventions, emphasizing the importance of contextual factors and multidisciplinary collaboration. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal governments, with a maximum funding amount of $275,000 and a project period of up to two years. Interested parties can find more information and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with applications due by May 7, 2025.
    Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)" aimed at supporting small-scale research projects that enhance health equity through genomic research. The initiative seeks to develop innovative approaches and metrics to ensure the equitable application of genomics in improving health outcomes for U.S. populations, particularly focusing on historically underrepresented groups in biomedical research. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofit organizations, and state governments, with funding available up to $200,000 annually for a maximum of two years. Interested parties should submit their applications by July 8, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-018.html.
    Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) grant, aimed at supporting studies that identify and test strategies to enhance the adoption and sustainability of evidence-based health interventions, particularly in underrepresented communities. The initiative focuses on overcoming barriers to the integration of these practices in healthcare settings while promoting equity in health outcomes, encouraging research that addresses both the effectiveness of health interventions and the dissemination strategies necessary for broad implementation. Eligible organizations include higher education institutions, nonprofits, and local governments, with grants of up to $50,000 per year available for a maximum of two years. Interested applicants must submit their proposals by May 7, 2025, and can find additional information and application instructions at http://grants.nih.gov/grants/guide/pa-files/PAR-22-106.html, or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) to support discrete scientific projects aligned with the interests of various NIH Institutes and Centers. This grant is specifically designed for projects that do not involve clinical trials, focusing instead on advancing health-related research and development. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal governments, with no fixed budget limits, although applicants must justify their requested funding. Interested parties should note that the application deadline is January 7, 2025, and can find more information by contacting the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visiting the official announcement at http://grants.nih.gov/grants/guide/pa-files/PA-20-185.html.